FDA APPROVES EIGHT NEW BIOLOGICALS IN 1996: AVERAGE TIME FOR USER FEE APPLICATIONS IS 19.8 MONTHS; VACCINES COULD FIGURE PROMINENTLY IN 1997 APPROVALS
Executive Summary
Two diphtheria/tetanus/acellular pertussis vaccines could figure among FDA's early 1997 approvals, with a third potentially to follow in the autumn.